Author:
Manzoor Saika,Ganie Mohd A.,Majid Sabhiya,Shabir Iram,Kawa Iram A.,Fatima Qudsia,Jeelani Humira,Yousuf Syed Douhath,Rashid Fouzia
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84:165–9.
2. Rosendal FR, Van Hylckma VA, Tanis BC, Helmerhorst FM. Estrogens, progestogens and thrombosis. J Thromb Haemost. 2003;1:1371–80.
3. Marnach ML, Long ME, Casey PM. Current issues in contraception. Mayo Clin Proc. 2013;88:295–9.
4. Yousuf SD, Ganie MA, Jeelani S, Mudassar S, Shah ZA, Zargar MA, Amin S, Wani IA, Rashid F. Effect of six-month use of oral contraceptive pills on plasminogen activator inhibitor-1 & factor VIII among women with polycystic ovary syndrome: an observational pilot study. Ind J Med Res. 2018;148:151–5.
5. Manzoor S, Ganie MA, Amin S, Shah ZA, Bhat IA, Yousuf SD, Jeelani H, Kawa IA, Fatima Q, Rashid F. Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: an observational study. Sci Rep. 2019;9:10182–9.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献